Alharby Essa, Bakhsh Mohammad A, Albalawi Alia M, Almutairi Sultan O, Hashmi Jamil A, Basit Sulman
Center for Genetics and Inherited Diseases, Taibah University Medina, Almadinah Almunawwarah , Saudi Arabia.
College of Applied Medical Science, Taibah University Medina, Almadinah Almunawwarah , Saudi Arabia.
Platelets. 2020 Jul 3;31(5):646-651. doi: 10.1080/09537104.2019.1663803. Epub 2019 Sep 5.
Inherited platelet function disorder-18 (IPD-18) is a relatively new non-syndromic autosomal recessive bleeding disorder. It is characterized by deficient or dysfunctional CalDAG-GEFI protein. The distinctive feature of the disease is impaired platelet aggregation in response to multiple physiologic agonists. We here report a family with a platelet-type bleeding disorder and a novel mutation in the gene. The overall bleeding score for the affected individuals was 15 and 12. Based on the initial diagnosis of Glanzmann thrombasthenia, targeted sequencing of integrin subunit alpha 2b and integrin subunit beta 3 encoding genes and were carried out in both affected members of a family. Sequence alignment failed to identify the disease-causing variant(s) in both genes. Therefore, whole exome sequencing in one affected individual was performed. Data analysis detected a novel homozygous missense variant (c.956C>T; p.Pro319Leu) in the exon 9 of the gene. Five additional individuals of a family including both parents, an affected individual and two asymptomatic individuals were Sanger sequenced for the variant (c.956C>T). The variant segregates in the family in an autosomal recessive manner. Several tools predicted the variant as pathogenic. Protein modeling studies suggest that the mutation (p.Pro319Leu) cause a conformational change in the loop structure of the RasGEF domain of the CalDAG-GEFI protein. Reported variants in the RasGEF domain impair expression and/or nucleotide exchange activity of CalDAG-GEFI protein and thus inhibit the activation of Rap1 protein required for platelet adhesion and hemostatic plug formation.
遗传性血小板功能障碍-18(IPD-18)是一种相对较新的非综合征性常染色体隐性出血性疾病。其特征是CalDAG-GEFI蛋白缺乏或功能异常。该疾病的显著特点是对多种生理激动剂的血小板聚集受损。我们在此报告一个患有血小板型出血性疾病且该基因存在新突变的家系。受影响个体的总体出血评分为15分和12分。基于最初诊断为Glanzmann血小板无力症,对一个家系的两名受影响成员进行了整合素α2b亚基和整合素β3亚基编码基因的靶向测序。序列比对未能在这两个基因中鉴定出致病变异。因此,对一名受影响个体进行了全外显子组测序。数据分析在该基因的第9外显子中检测到一个新的纯合错义变异(c.956C>T;p.Pro319Leu)。对该家系的另外五名个体(包括父母、一名受影响个体和两名无症状个体)进行了该变异(c.956C>T)的Sanger测序。该变异在家系中以常染色体隐性方式分离。几种工具预测该变异为致病性变异。蛋白质建模研究表明,该突变(p.Pro319Leu)导致CalDAG-GEFI蛋白RasGEF结构域的环结构发生构象变化。RasGEF结构域中报道的变异损害了CalDAG-GEFI蛋白的表达和/或核苷酸交换活性,从而抑制了血小板黏附和止血栓形成所需的Rap1蛋白的激活。